Abstract
ObjectivesDynamic study of B-cell using HSFC in systemic lupus erythematosus (SLE) patients’(pts) receiving anti-B-cell therapy with Rituximab (RTM) and definition of correlation with clinical and laboratory disease activity on the...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have